申请人:RANBAXY LAB LTD
公开号:WO2011161645A1
公开(公告)日:2011-12-29
The present invention relates to pyrazole derivatives and to processes for their synthesis as 5 -lipoxygenase (5-LO) inhibitors. The present invention also relates to pharmacological compositions containing these pyrazole derivatives, as well as methods of treating bronchial asthma, chronic obstructive pulmonary disease, rheumatoid arthritis, multiple sclerosis, Type I diabetes, psoriasis, allograft rejection, inflammatory bowel disease, ulcerative colitis, acne, atherosclerosis, cancer, pruritis, allergic rhinitis and other inflammatory and/or autoimmune disorders.
本发明涉及吡唑衍生物及其合成过程,作为5-脂氧合酶(5-LO)抑制剂。本发明还涉及含有这些吡唑衍生物的药理学组合物,以及治疗支气管哮喘、慢性阻塞性肺病、类风湿性关节炎、多发性硬化症、I型糖尿病、牛皮癣、移植排斥、炎症性肠病、溃疡性结肠炎、痤疮、动脉粥样硬化、癌症、瘙痒、过敏性鼻炎和其他炎症和/或自身免疫性疾病的治疗方法。